PHVS

Pharvaris N.V.

Healthcare · Biotechnology

$225.08 sample

-1.17 (-0.52%) 1D

Market cap

$198.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-13

Alerts

8

Price$225.08 +16.60% 3M daily closessample

226.25187.28

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13SEC8-K filed: material event
Oct 02SEC10-Q filed
Sep 24SECDEF 14A filed
Sep 17SECDEF 14A filed
Sep 10INSInsider sell: Director
Sep 02INSInsider buy: 10% owner
Aug 24SECDEF 14A filed
Aug 18SECForm 144 filed

Sign up to see the real PHVS record →

Company facts

SEC EDGAR registration

Name: Pharvaris N.V.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in PHVS

sample

Insiders: 19 insider transactions over 90 days, net selling, $496.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 19 funds hold $2.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.4B +18.5% y/y

Q4 2024Q3 2026

Inventory$5.5B +8.0% y/y

Q4 2024Q3 2026

Accounts receivable$4.2B +18.4% y/y

Q4 2024Q3 2026

Total debt$11.1B +8.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $61.8B -1.9% 3M
Sample peer B: $120.0B -7.4% 3M
Sample peer C: $109.1B -9.0% 3M
Sample peer D: $153.6B +10.2% 3M
Sample peer E: $34.5B -2.4% 3M